On 5 March 2021, the SCCS adopted an Opinion on Copper (nano) and Colloidal Copper (nano) [SCCS (Scientific Committee on Consumer Safety), Opinion on Copper (nano) and Colloidal Copper (nano), preliminary version of 27-28 October 2020, final version of 5 March 2021, SCCS/1621/2020.] (CAS No 7440-50-8), concluding that it is not possible to carry out a safety assessment due to the limited or missing essential information. However, the SCCS indicated that based on the available information from scientific literature and in the CPNP, a systemic uptake of Copper nanoparticle (and/or ionic Copper) is possible and could lead to accumulation in certain organs, notably the liver and spleen. In addition, the SCCS found that the potential mutagenic/genotoxic and immunotoxic/nephrotoxic effects of Copper nanomaterials raise concerns that warrants further safety evaluation of copper nanomaterials used as cosmetic ingredients.
Recital 3, Regulation (EU) 2024/858
In forcesince 14 Mar 2024